Plain-English translation of NCT07544680 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are collecting vaginal fluid samples from women to develop and test new ways of detecting endometrial cancer — cancer of the uterus lining — and related conditions. Right now, detecting these cancers often requires invasive biopsies. This study hopes to create simpler, less invasive tests using vaginal fluid that could catch cancer earlier and help more women get treated sooner.
Endometrial cancer is often caught late because current detection methods require uncomfortable procedures. By studying vaginal fluid samples, researchers hope to develop easier, non-invasive tests that could identify cancer or precancerous changes before they become serious.
If you're in the first group, you'll provide a vaginal fluid sample when you come in for your scheduled endometrial biopsy — the test your doctor already recommended. If you're in the second group with a confirmed diagnosis, you'll provide a sample as part of your initial treatment planning. The sample collection is simple and takes just a few minutes; researchers will then analyze these samples to help develop better detection tests.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
United States
Sponsor
Exact Sciences Corporation
Enrollment target
~4,200 participants
Started
March 2026
Primary completion
April 2028
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in October 2026.